Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × gedatolisib × Clear all

NCT02438761 2025-09-08

5

Phase 2 Terminated

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute